ADARx Pharmaceuticals Funding & Investors

San Diego, CA

ADARx Pharmaceuticals is a genetic medicine company focusing on the base editing of mRNA transcripts.

Total Amount Raised: $332,000,000

ADARx Pharmaceuticals Funding Rounds

Series C
$200,000,000
Aug 8, 2023
Series C Investors
Bain Capital Life Sciences
TCGX
Lilly Asia Ventures
Invus
Commodore Capital
OrbiMed Advisors
Ascenta Capital
T. Rowe Price
Cormorant Asset Management
Redmile Group
HBM Healthcare Investments
Venrock Healthcare Capital Partners
BlackRock
Marshall Wace
Vivo Capital
Sr One
Series B
$46,000,000
Jan 19, 2023
Series B Investors
Ascenta Capital
Sirona Capital
OrbiMed Advisors
Lilly Asia Ventures
Sr One
Series B
$75,000,000
Sep 7, 2021
Series B Investors
OrbiMed Advisors
Sr One
Sirona Capital
Lilly Asia Ventures
Series Unknown
$6,000,000
Nov 11, 2020
Seed
$5,000,000
Aug 3, 2020

Funding info provided by Diffbot.